论文部分内容阅读
目的:研究观察复方红豆杉胶囊治疗肝癌的临床疗效。方法:采用盲抽对照法将66例肝癌患者随机分为对照组和实验组各33例,对照组患者采用常规治疗,实验组患者加用复方红豆杉胶囊治疗,观察比较两组患者治疗效果。结果:经治疗,实验组患者治疗总有效率为90.9%,明显高于对照组的75.7%,差异具有统计学意义(P<0.05);治疗后,实验组患者肿瘤面积缩小情况和生活质量评分均优于对照组,差异具有统计学意义(P<0.05)。结论:在常规治疗基础上加用复方红豆杉胶囊治疗肝癌疗效明显,可提高患者治疗效果及生活质量,值得临床推广应用。
Objective: To observe the clinical efficacy of compound yew capsules in the treatment of liver cancer. Methods: Sixty-six patients with hepatocellular carcinoma were randomly divided into control group and experimental group with 33 patients in each group. Patients in control group were treated by conventional therapy. Patients in experimental group were treated with compound-yew capsules. The therapeutic effect was observed and compared between two groups. Results: After treatment, the total effective rate of the experimental group was 90.9%, significantly higher than that of the control group (75.7%), the difference was statistically significant (P <0.05); after treatment, the experimental group patients with tumor size reduction and quality of life score All were better than the control group, the difference was statistically significant (P <0.05). Conclusion: The treatment of hepatocarcinoma with compound yew capsules on the basis of conventional treatment has obvious curative effect, which can improve the therapeutic effect and quality of life of patients, and is worthy of clinical application.